ID #959 Group 3/4 Medulloblastoma of early childhood – risks and benefits of a CSI-sparing therapy approach in young childrenChristian Fiedler, Martin Mynarek, Marthe Sönksen et al.|Neuro-Oncology Pediatrics|2026Cited by 0